The cellular origins of drug resistance in cancer

Nature Medicine

Volumn 22, Issue 3, 2016, Pages 232-234

  Oxnard, Geoffrey R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; N [3 [[5 CHLORO 2 [[2 METHOXY 4 (4 METHYL 1 PIPERAZINYL)PHENYL]AMINO] 4 PYRIMIDINYL]OXY]PHENYL]ACRYLAMIDE; PROTEIN TYROSINE KINASE INHIBITOR; ANTINEOPLASTIC AGENT; PROTEIN KINASE INHIBITOR;

CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CLONE; DRUG RESISTANCE; GENE MUTATION; HUMAN; LUNG CANCER CELL LINE; NON SMALL CELL LUNG CANCER; ONCOGENE; PRIORITY JOURNAL; PROTO ONCOGENE; SHORT SURVEY; TREATMENT RESPONSE; TUMOR BIOPSY; ANTAGONISTS AND INHIBITORS; CARCINOMA, NON-SMALL-CELL LUNG; GENETICS; LUNG NEOPLASMS; MOLECULARLY TARGETED THERAPY; MUTATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENES, ERBB-1; HUMANS; LUNG NEOPLASMS; MOLECULAR TARGETED THERAPY; MUTATION; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84978699091     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4058     Document Type: Short Survey

References (12)

1. Hata, A.N. et al. Nat. Med. 22, 262-269 (2016).
2. Ramirez, M. et al. Nat. Commun. 7, doi:10.1038/ncomms10690 (19 February 2016).
3. Arcila, M.E. et al. Clin. Cancer Res. 17, 1169-1180 (2011).
4. Zhou, W. et al. Nature 462, 1070-1074 (2009).
5. Chmielecki, J. et al. Sci. Transl. Med. 3, 90ra59 (2011).
6. Jänne, P.A. et al. N. Engl. J. Med. 372, 1689-1699 (2015).
7. Ye, X., et al. J. Thorac. Oncol. 8, 1118-1120 (2013).
8. Sharma, S.V. et al. Cell 141, 69-80 (2010).
9. Engelman, J.A. et al. Science 316, 1039-1043 (2007).
10. Tricker, E.M. et al. Cancer Discov. 5, 960-971 (2015).
11. Oxnard, G.R. et al. Clin. Cancer Res. 20, 1698-1705 (2014).
12. Thress, K.S. et al. Nat. Med. 21, 560-562 (2015).